Harrow, Inc. is rapidly evolving into a dominant US ophthalmic pharma player, with a 30-fold revenue increase since 2015 and ...
At 60, after building 10 companies, I'm starting an AI startup from scratch — and it's the most important (and terrifying) one yet.